Renal failure and hyponatremia in patients with cirrhosis and skin and soft tissue infection. A retrospective study

Journal of Hepatology

Volumn 56, Issue 5, 2012, Pages 1040-1046

  Pereira, Gustavo ^a,b,c,d   Guevara, Mónica ^a,b,c,d   Fagundes, Claudia ^a,b,c,d   Solá, Elsa ^a,b,c,d   Rodríguez, Ezequiel ^a,b,c,d   Fernández, Javier ^a,b,c   Pavesi, Marco ^b,c   Arroyo, Vicente ^a,b,c   Ginès, Pere ^a,b,c,d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Instituto Reina Sofia de Investigación Nefrologia IRSIN   (Spain)

Author keywords

Acute on chronic liver failure; Hepatic encephalopathy; Hepatorenal syndrome

Indexed keywords

CARBAPENEM; CIPROFLOXACIN; SODIUM; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; ASCITES; BACTERIAL PERITONITIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HUMAN; HYPONATREMIA; KIDNEY FAILURE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SKIN AND SOFT TISSUE INFECTION; SKIN INFECTION; SODIUM BLOOD LEVEL; SOFT TISSUE INFECTION;

AGED; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPONATREMIA; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SKIN DISEASES; SOFT TISSUE INFECTIONS; SURVIVAL RATE;

EID: 84859336573     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.11.023     Document Type: Article

References (39)

1. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002;35:140-148. (Pubitemid 34032554)
2. Arvaniti V, D'Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010;139: 1246-1256.
3. Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 2008;28:26-42. (Pubitemid 351326531)
4. Wong F, Bernardi M, Balk R, Christman B, Moreau R, Garcia-Tsao G, et al. Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut 2005;54:718-725. (Pubitemid 40559261)
5. Gustot T, Durand F, Lebrec D, Vincent JL, Moreau R. Severe sepsis in cirrhosis. Hepatology 2009;50:2022-2033.
6. Martin-Llahi M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011;140:488-496.
7. Martin PY, Ohara M, Gines P, Xu DL, St John J, Niederberger M, et al. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites. J Clin Invest 1998;101:235-242. (Pubitemid 28058923)
8. Fernández J, Monteagudo J, Bargallo X, Jimenez W, Bosch J, Arroyo V, et al. Randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology 2005;42:627-634. (Pubitemid 41233655)
9. Arroyo V, Terra C, Gines P. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome. J Hepatol 2007;46:935-946. (Pubitemid 46529046)
10. Ruiz-del-Arbol L, Urman J, Fernandez J, Gonzalez M, Navasa M, Monescillo A, et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003;38: 1210-1218. (Pubitemid 37314829)
11. Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-409. (Pubitemid 29362513)
12. Navasa M, Follo A, Filella X, Jimenez W, Francitorra A, Planas R, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology 1998;27:1227-1232. (Pubitemid 28227848)
13. Terra C, Guevara M, Torre A, Gilabert R, Fernandez J, Martin-Llahi M, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005;129: 1944-1953. (Pubitemid 41772972)
14. Fasolato S, Angeli P, Dallagnese L, Maresio G, Zola E, Mazza E, et al. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 2007;45:223-229. (Pubitemid 46144382)
15. Corredoira JM, Ariza J, Pallares R, Carratala J, Viladrich PF, Rufi G, et al. Gram-negative bacillary cellulitis in patients with hepatic cirrhosis. Eur J Clin Microbiol Infect Dis 1994;13:19-24. (Pubitemid 24060884)
16. Horowitz Y, Sperber AD, Almog Y. Gram-negative cellulitis complicating cirrhosis. Mayo Clin Proc 2004;79:247-250. (Pubitemid 38140810)
17. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693-699. (Pubitemid 26079803)
18. Cárdenas A, Ginès P. Management of complications of cirrhosis in patients awaiting liver transplantation11. J Hepatol 2005;42:S124-S133. (Pubitemid 40364612)
19. Solà E, Lens S, Guevara M, Martin-Llahi M, Fagundes C, Pereira G, et al. Hyponatremia in patients treated with terlipressin for severe gastrointestinal bleeding due to portal hypertension. Hepatology 2010;52:1783-1790.
20. Venditti M, Falcone M, Corrao S, Licata G, Serra P. Study Group of the Italian Society of Internal Medicine. Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 2009;6 (150):19-26.
21. Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M, et al. Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol 2010;8:979-985.
22. Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis prevention and treatment of the hepatorenal syndrome in cirrhosis. A consensus workshop of the international ascites club. Gut 2007;56:1310-1318. (Pubitemid 47300435)
23. Kim JH, Lee JS, Lee SH, Bae WK, Kim NH, Kim KA, et al. Renal dysfunction induced by bacterial infection other than spontaneous bacterial peritonitis in patients with cirrhosis: incidence and risk factor. Gut Liver 2009;3:292-297.
24. Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology 2008;48:2064-2077.
25. Terg R, Gadano A, Cartier M, Casciato P, Lucero R, Munoz A, et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study. Liver Int 2009;29:415-419.
26. Figtree M, Konecny P, Jennings Z, Goh C, Krilis SA, Miyakis S. Risk stratification and outcome of cellulitis admitted to hospital. J Infect 2010;60:431-439.
27. Ginès P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009;361:1279-1290.
28. Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, et al. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology 1994;20:1495-1501. (Pubitemid 24359062)
29. Porcel A, Diaz F, Rendon P. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med 2002;162:323-328. (Pubitemid 34127410)
30. Guevara M, Baccaro ME, Torre A, Gomez-Anson B, Rios J, Torres F, et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol 2009;104:1382-1389.
31. Heuman DM, Bou-Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology 2004;40:802-810. (Pubitemid 39288112)
32. Wright G, Jalan R. Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: pandora's box? Hepatology 2007;46:291-294. (Pubitemid 47344761)
33. Córdoba J, Minguez B. Hepatic encephalopathy. Semin Liver Dis 2008;28:70-80. (Pubitemid 351326534)
34. Cazzaniga M, Dionigi E, Gobbo G, Fioretti A, Monti V, Salerno F. The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome. J Hepatol 2009;51:475-482.
35. Thabut D, Massard J, Gangloff A, Carbonell N, Francoz C, Nguyen-Khac E, et al. Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure. Hepatology 2007;46:1872-1882.
36. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008;359:1018-1026.
37. Cheong HS, Kang CI, Lee JA, Moon SY, Joung MK, Chung DR. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis 2009 May 1;48 (9):1230-1236.
38. Carratala J, Roson B, Fernandez-Sabe N, Shaw E, Del RO, Rivera A, et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis 2003;22:151-157. (Pubitemid 36461364)
39. Jenkins TC, Sabel AL, Sarcone EE, Price CS, Mehler PS, Burman WJ. Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship. Clin Infect Dis 2010;51:895-903.